Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas
Sharmistha Pal, David Kozono, Xiaodong Yang, et al.
Cancer Research (2018) Vol. 78, Iss. 14, pp. 4007-4021
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

The p53 Pathway in Glioblastoma
Ying Zhang, Collin Dube, Myron Gibert, et al.
Cancers (2018) Vol. 10, Iss. 9, pp. 297-297
Open Access | Times Cited: 346
The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
Li Guo, Yuan Tian, Wei‐Guo Zhu
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 269
Glioblastoma: Current Status, Emerging Targets, and Recent Advances
Amandeep Thakur, Chetna Faujdar, Ram Sharma, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 13, pp. 8596-8685
Open Access | Times Cited: 68
Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies
Izac J. Findlay, Geoffry N. De Iuliis, Ryan J. Duchatel, et al.
Oncogene (2021) Vol. 41, Iss. 4, pp. 461-475
Open Access | Times Cited: 60
A druggable addiction to de novo pyrimidine biosynthesis in diffuse midline glioma
Sharmistha Pal, Jakub Kaplan, Huy Nguyen, et al.
Cancer Cell (2022) Vol. 40, Iss. 9, pp. 957-972.e10
Open Access | Times Cited: 54
Metabolic Roles of HIF1, c-Myc, and p53 in Glioma Cells
Cristina Trejo‐Solís, Rosa Angélica Castillo‐Rodríguez, Norma Serrano‐García, et al.
Metabolites (2024) Vol. 14, Iss. 5, pp. 249-249
Open Access | Times Cited: 10
Current and future therapeutic strategies for high-grade gliomas leveraging the interplay between epigenetic regulators and kinase signaling networks
Lea Stitzlein, Jack T. Adams, Erin N. Stitzlein, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 8
Sequential Targeting in Crosslinking Nanotheranostics for Tackling the Multibarriers of Brain Tumors
Hao Wu, Hongwei Lu, Wenwu Xiao, et al.
Advanced Materials (2020) Vol. 32, Iss. 14
Open Access | Times Cited: 61
Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective
Yuan Gao, Hang Zhang, Frédéric Lirussi, et al.
Biochemical Pharmacology (2020) Vol. 182, pp. 114224-114224
Open Access | Times Cited: 60
Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312)
Kristina A. Cole, Sharmistha Pal, Rachel A. Kudgus, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 6, pp. 1213-1219
Open Access | Times Cited: 56
Pathogenetic Features and Current Management of Glioblastoma
Hong-My Nguyen, Kirsten Guz-Montgomery, Devin B. Lowe, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 856-856
Open Access | Times Cited: 50
FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis
Sheng‐Kai Liang, Chia-Chan Hsu, Hsiang‐Lin Song, et al.
Oncogene (2021) Vol. 40, Iss. 30, pp. 4847-4858
Closed Access | Times Cited: 44
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma
Chen He, Ke Xu, Xiaoyan Zhu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 44
Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma
Lauren Arms, Ryan J. Duchatel, Evangeline R. Jackson, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 835-865
Open Access | Times Cited: 6
CUDC‐907, a novel dual PI3K and HDAC inhibitor, in prostate cancer: Antitumour activity and molecular mechanism of action
Cheng Hu, Hongyan Xia, Shanshan Bai, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 13, pp. 7239-7253
Open Access | Times Cited: 42
Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential
Alexandre Perla, Lívia Fratini, Paula Schoproni Cardoso, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 40
Dual Targeting of PI3K and HDAC by CUDC-907 Inhibits Pediatric Neuroblastoma Growth
Rameswari Chilamakuri, Saurabh Agarwal
Cancers (2022) Vol. 14, Iss. 4, pp. 1067-1067
Open Access | Times Cited: 24
Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics
Peyman Tabnak, Aysa Hasanzade Bashkandi, Mohammad Ebrahimnezhad, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 16
Therapeutic Targets in Diffuse Midline Gliomas—An Emerging Landscape
Elisha Hayden, Holly Holliday, Rebecca Lehmann, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6251-6251
Open Access | Times Cited: 32
Molecular Genetics and Targeted Therapies for Paediatric High-grade Glioma
Kathrine S Rallis, Alan Mathew George, Anna Maria Wozniak, et al.
Cancer Genomics & Proteomics (2022) Vol. 19, Iss. 4, pp. 390-414
Open Access | Times Cited: 22
Synergistic antitumor effect of MK-1775 and CUDC-907 against prostate cancer
Saisai Ma, Yichen Xu, Minmin Liu, et al.
Investigational New Drugs (2025)
Closed Access
Regulation of FOXM1 by HDAC3 Inhibition Ameliorates Macrophage Endoplasmic Reticulum stress and Apoptosis in Mycobacterium tuberculosis Infection
Jin-qi Hao, Lanwei Zhang, Jia Jia Qi, et al.
Immunobiology (2025) Vol. 230, Iss. 2, pp. 152879-152879
Open Access
Phase I Study of Vorinostat and Temsirolimus in Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma
Lea Stitzlein, Muhammad Usman Baig, Joya Chandra, et al.
Pediatric Blood & Cancer (2025)
Closed Access
The dual HDAC/PI3K inhibitor CUDC-907 inhibits the growth and proliferation of MYC-driven Group 3 medulloblastoma
Pan Gou, Chencheng Fang, Man Xu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Molecular mechanisms involved in DNA repair in human cancers: An overview of PI3k/Akt signaling and PIKKs crosstalk
Forough Alemi, Aydin Raei Sadigh, Faezeh Malakoti, et al.
Journal of Cellular Physiology (2021) Vol. 237, Iss. 1, pp. 313-328
Closed Access | Times Cited: 25
Page 1 - Next Page

Scroll to top